Takeda Pharmaceutical Company Limited Work In Progress
Takeda Pharmaceutical Company Limited (TKPHF) had Work In Progress of JPY 552.20 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:WorkInProgress · last filed 2025-06-25
- 2025-03-31: Work In Progress 552.20B JPY.
- 2024-03-31: Work In Progress 522.67B JPY.
- 2023-03-31: Work In Progress 436.51B JPY.
- 2022-03-31: Work In Progress 404.09B JPY.
| Period end | Work In Progress | Work In Progress as first filed |
|---|---|---|
| 2025-03-31 | 552.20B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 522.67B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 436.51B JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 404.09B JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 387.92B JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 395.84B JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 490.75B JPY 20-F · filed 2020-06-24 | 544.41B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 63.15B JPY 20-F · filed 2019-06-27 |